Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The coronavirus disease 2019 (COVID-19) pandemic disrupted the emergency medical care system worldwide. We analyzed the changes in the management of intracerebral hemorrhage (ICH) and compared the pre-COVID-19 and COVID-19 eras. Materials and Methods: From March to October of the COVID-19 era (2020), 83 consecutive patients with ICH were admitted to four comprehensive stroke centers. We retrospectively reviewed the data of patients and compared the treatment workflow metrics, treatment modalities, and clinical outcomes with the patients admitted during the same period of pre-COVID-19 era (2017–2019). Results: Three hundred thirty-eight patients (83 in COVID-19 era and 255 in pre-COVID-19 era) were included in this study. Symptom onset/detection-to-door time [COVID-19; 56.0 min (34.0–106.0), pre-COVID-19; 40.0 min (27.0–98.0), p=0.016] and median door to-intensive treatment time differed between the two groups [COVID-19; 349.0 min (177.0–560.0), pre-COVID-19; 184.0 min (134.0–271.0), p<0.001]. Hematoma expansion was detected more significantly in the COVID-19 era (39.8% vs. 22.1%, p=0.002). At 3-month follow-up, clinical outcomes of patients were worse in the COVID-19 era (Good modified Rankin Scale; 33.7% in COVID-19, 46.7% in pre-COVID-19, p=0.039). Conclusion: During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes.
Abstract
Purpose: The coronavirus disease 2019 (COVID-19) pandemic disrupted the emergency medical care system worldwide. We analyzed the changes in the management of intracerebral hemorrhage (ICH) and compared the pre-COVID-19 and COVID-19 eras. Materials and Methods: From March to October of the COVID-19 era (2020), 83 consecutive patients with ICH were admitted to four comprehensive stroke centers. We retrospectively reviewed the data of patients and compared the treatment workflow metrics, treatment modalities, and clinical outcomes with the patients admitted during the same period of pre-COVID-19 era (2017–2019). Results: Three hundred thirty-eight patients (83 in COVID-19 era and 255 in pre-COVID-19 era) were included in this study. Symptom onset/detection-to-door time [COVID-19; 56.0 min (34.0–106.0), pre-COVID-19; 40.0 min (27.0–98.0), p=0.016] and median door to-intensive treatment time differed between the two groups [COVID-19; 349.0 min (177.0–560.0), pre-COVID-19; 184.0 min (134.0–271.0), p<0.001]. Hematoma expansion was detected more significantly in the COVID-19 era (39.8% vs. 22.1%, p=0.002). At 3-month follow-up, clinical outcomes of patients were worse in the COVID-19 era (Good modified Rankin Scale; 33.7% in COVID-19, 46.7% in pre-COVID-19, p=0.039). Conclusion: During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes.
참고문헌 (32)
- Mahase E, "COVID-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction", BMJ, 368, pp.m1036~ (2020)
- Schrag D, "Oncology practice during the COVID-19 pandemic", JAMA, 323, pp.2005~2006 (2020)
- Tam CF, "Impact of coronavirus disease 2019(COVID-19)outbreak on ST-segment–elevation myocardial infarction care in Hong Kong, China", Circ Cardiovasc Qual Outcomes, 13, pp.e006631~ (2020)
- Rudilosso S, "Acute stroke care is at risk in the era of COVID-19 : experience at a comprehensive stroke center in Barcelona", Stroke, 51, pp.1991~1995 (2020)
- Teo KC, "Delays in stroke onset to hospital arrival time during COVID-19", Stroke, 51, pp.2228~2231 (2020)
- Keun-Sik Hong, "Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke", 대한뇌졸중영문학회지, 15(1), pp.2~20 (2013), 대한뇌졸중학회[DOI]
- Qureshi AI, "Intracerebral haemorrhage", Lancet, 373, pp.1632~1644 (2009)
- Kazunori Toyoda, "Epidemiology and Registry Studies of Stroke in Japan", 대한뇌졸중영문학회지, 15(1), pp.21~26 (2013), 대한뇌졸중학회[DOI]
- van Asch CJ, "Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin : a systematic review and meta-analysis", Lancet Neurol, 9, pp.167~176 (2010)
- Anderson CS, "Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage", N Engl J Med, 368, pp.2355~2365 (2013)
- Diringer MN, "Admission to a neurologic", neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage, 2001, pp.29, 635~640
- Naval NS, "Impact of pattern of admission on ICH outcomes", Neurocrit Care, 12, pp.149~154 (2010)
- Varelas PN, "The impact of a neuro-intensivist on patients with stroke admitted to a neurosciences intensive care unit", Neurocrit Care, 9, pp.293~299 (2008)
- Brouwers HB, "Predicting hematoma expansion after primary intracerebral hemorrhage", JAMA Neurol, 71, pp.158~164 (2014)
- Pandey AS, "Letter : COVID-19 pandemic—the bystander effect on stroke care in Michigan", Neurosurgery, 87, pp.E397~9 (2020)
- Estevez-Ordonez D, "Perioperative and critical care management of a patient with severe acute respiratory syndrome corona virus 2 infection and aneurysmal subarachnoid hemorrhage", Neurosurgery, 87, pp.E243~4 (2020)
- "Korea Centers for Disease Control and Prevention guidelines for COVID-19 in medical institutions"[URL]
- Brott T, "Early hemorrhage growth in patients with intracerebral hemorrhage", Stroke, 28, pp.1~5 (1997)
- Brouwers HB, "CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage", Neurocrit Care, 17, pp.421~428 (2012)
- Goldstein JN, "Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage", Neurology, 68, pp.889~894 (2007)
- Li Q, "Island sign : an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage", Stroke, 48, pp.3019~3025 (2017)
- Nguyen TN, "Mechanical thrombectomy in the era of the COVID-19 pandemic : emergency preparedness for neuroscience teams : a guidance statement from the Society of Vascular and Interventional Neurology", Stroke, 51, pp.1896~1901 (2020)
- Smith MS, "Endovascular therapy for patients with acute ischemic stroke during the COVID-19 pandemic : a proposed algorithm", Stroke, 51, pp.1902~1909 (2020)
- Kurz MW, "Improving stroke care in times of the COVID-19 pandemic through simulation: practice your protocols!", Stroke, 51, pp.2273~2275 (2020)
- Cooper D, "Critical pathways for the management of stroke and intracerebral hemorrhage : a survey of US hospitals", Crit Pathw Cardiol, 6, pp.18~23 (2007)
- Zhao J, "Impact of the COVID-19 epidemic on stroke care and potential solutions", Stroke, 51, pp.1996~2001 (2020)
- Kerleroux B, "Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak : decreased activity, and increased care delays", Stroke, 51, pp.2012~2017 (2020)
- Diegoli H, "Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era", Stroke, 51, pp.2315~2321 (2020)
- Butcher KS, "The intracerebral hemorrhage acutely decreasing arterial pressure trial", Stroke, 44, pp.620~626 (2013)
- Sakamoto Y, "Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage : the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study", Stroke, 44, pp.1846~1851 (2013)
- Zazulia AR, "Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage", J Cereb Blood Flow Metab, 21, pp.804~810 (2001)
- Huhtakangas J, "Effect of increased warfarin use on warfarin-related cerebral hemorrhage : a longitudinal population-based study", Stroke, 42, pp.2431~2435 (2011)